1. Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects
- Author
-
Maarten van Kleef, Ingemar S. J. Merkies, Janneke G. J. Hoeijmakers, Margot Geerts, Catharina G. Faber, Brigitte A. Brouwer, Bianca T. A. de Greef, MUMC+: MA Anesthesiologie (9), Klinische Neurowetenschappen, RS: MHeNs - R3 - Neuroscience, MUMC+: MA Niet Med Staf Neurologie (9), MUMC+: TPZ Diabetes Zorg (9), and Anesthesiologie
- Subjects
medicine.medical_specialty ,Geriatrics gerontology ,business.industry ,Pharmacology toxicology ,Review Article ,Erythromelalgia ,medicine.disease ,3. Good health ,Physical medicine and rehabilitation ,Pharmacotherapy ,Current management ,Neuropathic pain ,medicine ,Neuralgia ,Humans ,Pharmacology (medical) ,Geriatrics and Gerontology ,Small Fiber Neuropathy ,business ,Aged - Abstract
Over the last 10 years, the diagnosis small fiber neuropathy (SFN) has gained recognition worldwide. Patients often suffer from severe neuropathic pain that may be difficult to treat. A substantial subset of patients with SFN is aged 65 years or older, and these patients often exhibit comorbidities and usage of multiple drugs, making neuropathic pain treatment more challenging. In this review, we highlight relevant pathophysiological aspects and discuss currently used therapeutic strategies for neuropathic pain. Possible pitfalls in neuropathic pain treatment in the elderly will be underlined.
- Published
- 2015